Revance Therapeutics Inc (RVNC) Dividend History
Revance Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
Last update 05/31/2023
Dividend Yield Summary
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 27.84 | 14.39 | 23.17 | 25.39 | 18.46 | 31.73 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |